Presentation

National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey

Mar 10, 2025, 14:00 PM
Burden of Illness and Healthcare Resource Utilization (HCRU) for Chronic Obstructive Pulmonary Disease (COPD) in Ontario, Canada

Mar 10, 2025, 14:00 PM
Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring:A Population-Based Study

Mar 10, 2025, 14:00 PM
Characterizing the Contribution of RWE in Healthcare Decision-Making in Oncology

Mar 10, 2025, 14:00 PM
GenAI Goes to ISPOR: Exploratory, Descriptive Analysis of Generative AI Performance for Summarizing and Synthesizing ISPOR Research Abstracts as Sources

Mar 10, 2025, 14:00 PM
A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review

Mar 10, 2025, 14:00 PM
Clinical Value of Testing for c-Met Protein Overexpression in Patients With Non-Small Cell Lung Cancer

Mar 10, 2025, 14:00 PM
Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study

Mar 10, 2025, 14:00 PM
Integration of Survival Analysis Outputs Into Excel-Based Cost-Effectiveness Models Using Generative AI

Mar 10, 2025, 14:00 PM
Evaluating the Effects of the COVID-19 Pandemic on ICU Mortality and Sedation Charges in Mechanically Ventilated Patients

Mar 10, 2025, 14:00 PM
Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review

Mar 10, 2025, 14:00 PM
Hospitalization Risk Among Adults With Atopic Dermatitis in Brazil's Public Health System

Mar 10, 2025, 14:00 PM
Costs And Healthcare Resource Utilization In Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review

Mar 10, 2025, 14:00 PM
Amelioration of Indirect Costs Following COVID-19 Infection in High-Risk US Patients Treated With Nirmatrelvir-Ritonavir

Mar 10, 2025, 14:00 PM
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Mar 10, 2025, 14:00 PM
An Overview of Pricing and Reimbursement Frameworks for Medicinal Products in Central and Eastern European (CEE) Countries: Mechanisms, Rules, And Managed Entry Agreements (MEAs)

Mar 10, 2025, 14:00 PM
Audience and Publication Profiles in HEOR Research: A Cross-Sectional Analysis of Non-Small-Cell Lung Cancer and Coronary Artery Disease Studies in 2024

Mar 10, 2025, 14:00 PM
Sex-Stratified Differences in Cardiac Interventions, Complications and Outcomes in the Netherlands Between 2018 and 2023

Mar 10, 2025, 14:00 PM
Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data

Mar 10, 2025, 14:00 PM
Outcomes of Outpatient Administration of Ciltacabtagene Autoleucel (Cilta-Cel) in Relapsed Refractory Multiple Myeloma (RRMM)

Mar 10, 2025, 14:00 PM

Presentation (CTI)

National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey

Burden of Illness and Healthcare Resource Utilization (HCRU) for Chronic Obstructive Pulmonary Disease (COPD) in Ontario, Canada

Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring:A Population-Based Study

Characterizing the Contribution of RWE in Healthcare Decision-Making in Oncology

GenAI Goes to ISPOR: Exploratory, Descriptive Analysis of Generative AI Performance for Summarizing and Synthesizing ISPOR Research Abstracts as Sources

A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review

Clinical Value of Testing for c-Met Protein Overexpression in Patients With Non-Small Cell Lung Cancer

Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study

Integration of Survival Analysis Outputs Into Excel-Based Cost-Effectiveness Models Using Generative AI

Evaluating the Effects of the COVID-19 Pandemic on ICU Mortality and Sedation Charges in Mechanically Ventilated Patients

Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review

Hospitalization Risk Among Adults With Atopic Dermatitis in Brazil's Public Health System

Costs And Healthcare Resource Utilization In Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review

Amelioration of Indirect Costs Following COVID-19 Infection in High-Risk US Patients Treated With Nirmatrelvir-Ritonavir

Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

An Overview of Pricing and Reimbursement Frameworks for Medicinal Products in Central and Eastern European (CEE) Countries: Mechanisms, Rules, And Managed Entry Agreements (MEAs)

Audience and Publication Profiles in HEOR Research: A Cross-Sectional Analysis of Non-Small-Cell Lung Cancer and Coronary Artery Disease Studies in 2024

Sex-Stratified Differences in Cardiac Interventions, Complications and Outcomes in the Netherlands Between 2018 and 2023

Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data

Outcomes of Outpatient Administration of Ciltacabtagene Autoleucel (Cilta-Cel) in Relapsed Refractory Multiple Myeloma (RRMM)

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Your browser is out-of-date